Program
platelet rich plasma
Also written as “Platelet-Rich Plasma (PRP) Injections”, “[PRP] platelet rich plasma” and “Autologous PRP Gel and PRP Injection”.
Its studies are mostly in Osteoarthritis · Alopecia · Osteoarthritis, Knee · Diphtheria · Pain, led by 8 companies.
Drug pagePlatelet rich plasma: every studyMany companies study it; this page follows only the 8 they lead. All 326 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Bioheartits history only | 10 open or running | phase 1since Mar 15, 2017 | Mar 15, 2017 | none ahead |
| Exactechits history only | 10 open or running | phase 4since Jan 20, 2009 | Jan 20, 2009 | none ahead |
| Integrant Ptyits history only | 11 open or running | phase 3since Mar 26, 2025 | Mar 26, 2025 | Aug 2027phase 3 · NCT06907121 |
| Kimberly Meathrelits history only | 11 open or running | early phase 1since Jul 28, 2026 | Jul 28, 2026 | Dec 30, 2027early phase 1 · NCT07739147 |
| PT. Prodia Stem Cell Indonesiaits history only | 11 open or running | phase 2since Feb 17, 2026 | Feb 17, 2026 | none ahead |
| QC Kinetixits history only | 10 open or running | phase 2since Feb 6, 2023 | Feb 6, 2023 | none ahead |
| TotipotentRX Cell Therapy Pvt. | 10 open or running | phase 1since Jan 4, 2017 | Jan 4, 2017 | none ahead |
| Zimmer Biometits history only | 10 open or running | no phasesince Sep 22, 2008 | Sep 22, 2008 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of TotipotentRX Cell Therapy Pvt. only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 4, 2017First study: phase 1 study in Chronic UlcerFirst studyNCT03026855 · 24 enrolled · India
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
The one study TotipotentRX Cell Therapy Pvt. leads. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT03026855Chronic Ulcer · India | 1 | Completed | Apr 2016 | 24 |
How it is read
Names in the registry
- “Platelet-Rich Plasma (PRP) Injections”, 2 entries
- “[PRP] platelet rich plasma”, 2 entries
- “Autologous PRP Gel and PRP Injection”, 2 entries
- “Intra-Articular Injection of Growth Hormone and Platelet-Rich Plasma”, 1 entry
- “Ibuprofen and PRP”, 1 entry
Conditions, from the studies’ own filings
- Osteoarthritis, 3 studies
- Alopecia, 2 studies
- Osteoarthritis, Knee, 1 study
- Diphtheria, 1 study
- Pain, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.